Bnp Paribas Asset Management Holding S.A. Rocket Pharmaceuticals, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 803 shares of RCKT stock, worth $2,529. This represents 0.0% of its overall portfolio holdings.
Number of Shares
803Holding current value
$2,529% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RCKT
# of Institutions
221Shares Held
98.4MCall Options Held
611KPut Options Held
474K-
Rtw Investments, LP New York, NY17.7MShares$55.7 Million0.67% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.36MShares$26.3 Million0.35% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$19.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.12MShares$19.3 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.82MShares$15.2 Million0.17% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $238M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...